Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: MoneyMade who wrote (554)	2/3/1999 4:37:00 PM
From: Dan Spillane	Read Replies (1) \| Respond to of 1298

What's going on today to move the stock? Is it simply the vastly improved long-term prospects(and balance sheet) that people are just realizing? I only just realized something myself. The recent Parkinson's news (which didn't move the stock much) actually represents more than it appears. To wit, doesn't Cell Genesys have a patent on the delivery system to the brain?!? Remember, the key is NOT entirely the gene itself, but the delivery...in other words, making the expression of the gene work in the first place and subsequently persist is most important. ...you can do all the genomic studies in the world, but they aren't worth anything unless the genes are properly deployed...